KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to $8.4 million.

  • Globus Medical's Change in Receivables rose 13560.29% to $8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$34.5 million, marking a year-over-year decrease of 13035.43%. This contributed to the annual value of $78.1 million for FY2024, which is 5639.3% up from last year.
  • Latest data reveals that Globus Medical reported Change in Receivables of $8.4 million as of Q3 2025, which was up 13560.29% from $2.2 million recorded in Q2 2025.
  • Over the past 5 years, Globus Medical's Change in Receivables peaked at $87.8 million during Q2 2024, and registered a low of -$23.7 million during Q3 2024.
  • For the 5-year period, Globus Medical's Change in Receivables averaged around $10.1 million, with its median value being $8.4 million (2025).
  • As far as peak fluctuations go, Globus Medical's Change in Receivables surged by 51096.65% in 2023, and later tumbled by 37146.63% in 2024.
  • Globus Medical's Change in Receivables (Quarter) stood at $6.0 million in 2021, then fell by 22.19% to $4.6 million in 2022, then surged by 179.15% to $13.0 million in 2023, then plummeted by 273.47% to -$22.5 million in 2024, then surged by 137.47% to $8.4 million in 2025.
  • Its last three reported values are $8.4 million in Q3 2025, $2.2 million for Q2 2025, and -$22.6 million during Q1 2025.